$AMPE Try this on from 2011 Positive results for intranasal Ampion Ampio Pharmaceuticals has announced results of a randomized, double-blinded study of its intranasal Ampion, a biologic anti-inflammatory, for the treatment of nasal inflammation. According to the company, Ampion “is naturally produced by humans in response to injury and is present in commercial human serum albumin (HSA) preparations.” Ampio is also developing oral and injectable forms of the drug. The study, which was conducted at Centers for Allergy and Asthma in Denver, involved 20 patients who received either intranasal Ampion or saline and found statistically significant improvement in total nasal symptom scores for Ampion compared to placebo in moderately symptomatic patients.
  • 20
  • 4